Superworth

Diagnostics and research stocks with the lowest price to sales ratio

Market value divided by revenue over the last twelve months. As of .

Ranked
61
of 74 diagnostics and research stocks we cover
Median
4.5×
Lowest
0.3×
AMS
Range
0.3× to 61.9×
median 4.5×
0.3×56.0×
#CompanyP/SNet marginRevenue growth (TTM)Market cap
1AMSAmerican Shared Hospital Services0.3×−5.8%+4.0%$8.3M
2BIAFbioAffinity Technologies0.3×n/m−23.2%$1.6M
3QDELQuidelOrtho0.4×−39.2%−2.5%$962.1M
4HBIOHarvard Bioscience0.4×−11.9%−1.1%$39.1M
5BNGOBionano Genomics0.5×n/m+10.0%$13.7M
6MYGNMyriad Genetics0.7×−14.0%−3.2%$559.6M
7FTREFortrea0.7×−2.6%−3.4%$1.9B
8QTRXQuanterix0.9×−80.2%+22.0%$132.9M
9BGLCBioNexus Gene Lab0.9×−82.4%−67.3%$2.9M
10RPIDRapid Micro Biosystems1.0×n/m+16.1%$35.3M
11VNRXVolitionrx1.2×n/m+86.3%$2.9M
12PRPOPrecipio1.2×−4.5%+28.0%$31.8M
13AVTRAvantor1.6×−8.8%−1.6%$10.6B
14FLGTFulgent Genetics1.6×−26.0%+6.8%$530.8M
15BMRABiomerica1.8×n/m−11.2%$8M
16LHLabcorp2.0×7.0%+6.4%$28.9B
17BDSXBiodesix2.2×−27.0%+34.5%$229.8M
18DGXQuest Diagnostics2.3×9.5%+9.1%$27.5B
19BRKRBruker2.4×−2.0%+1.6%$8.5B
20IQVIQVIA2.5×8.1%+8.2%$42.5B
21RDNTRadNet2.5×−0.9%+18.9%$5.8B
22XGNExagen2.9×−26.6%+20.8%$203.3M
23NEOGNeogen2.9×−6.3%−0.3%$2.6B
24CSTLCastle Biosciences3.0×−5.4%+3.2%$1.1B
25ICCCImmucell3.1×2.6%+8.5%$95.9M
26CTKBCytek Biosciences3.6×−39.0%+5.4%$750M
27BIOBio-Rad Laboratories3.8×8.6%+1.4%$9.8B
28NRCNRC Health3.8×4.2%−0.2%$536.6M
29CRLCharles River Laboratories International4.0×−6.0%−0.7%$16.2B
30LNTHLantheus4.2×17.7%+2.3%$6.5B
31ISPCiSpecimen4.5×n/m−92.1%$2.1M
32PACBPacific Biosciences of California4.6×−82.5%+2.0%$728.9M
33MXCTMaxcyte4.8×n/m−13.2%$149.6M
34TMOThermo Fisher Scientific5.4×14.9%+8.3%$256.9B
35RVTYRevvity5.8×8.2%+4.1%$16.9B
36DHRDanaher6.3×16.9%+5.5%$162.6B
37MEDPMedpace6.5×17.7%+24.7%$18.1B
38AAgilent Technologies6.7×19.5%+8.6%$49.6B
39SEERSeer6.7×n/m−12.7%$95.8M
40MASS908 Devices6.9×−57.0%+13.4%$422M
41VCYTVeracyte7.0×20.4%+17.3%$3.9B
42ILMNIllumina8.0×18.4%+4.9%$35.7B
43MTDMettler-Toledo International8.3×21.9%+6.9%$34.2B
44TKNOAlpha Teknova8.6×−38.4%+12.3%$376.4M
45CDNACareDx9.1×25.9%+38.9%$4.5B
46CAICaris Life Sciences9.2×10.6%+85.4%$9.1B
47WATWaters10.0×3.6%+52.5%$46.4B
48ASTCASTROTECH10.4×n/m−12.9%$9.5M
49IDXXIDEXX Laboratories11.4×25.0%+12.8%$52.1B
50EYPTEyePoint11.6×n/m−94.6%$32.3M
51TXG10x Genomics13.0×−12.2%−4.3%$8B
52BLLNBillionToOne13.1×9.5%+90.1%$5.2B
53ONMDOneMedNet17.4×n/m+216.5%$25.4M
54OABIOmniAb18.5×n/m+90.6%$742.4M
55GHGuardant Health20.0×−38.3%+42.7%$23.7B
56NTRANatera20.7×−7.1%+37.8%$56.2B
57PSNLPersonalis24.2×n/m−13.3%$1.7B
58NTLAIntellia Therapeutics27.5×n/m+12.6%$1.6B
59GRALGRAIL36.2×n/m+23.1%$6B
60IMDXInsight Molecular Diagnostics56.0×n/m−60.8%$93.6M
61ACONAclarion61.9×n/m+33.1%$5.2M

Not ranked: 4 with a value too high to mean anything, 4 with not a meaningful number, 2 with a quarter missing. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

P/S for other groups

Other rankings of diagnostics and research stocks

The group